Trials / Completed
CompletedNCT03715790
Improve SCA Bridge Study
Improve Sudden Cardiac Arrest (SCA) Bridge Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,491 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the Improve SCA Bridge study is to characterize the care pathway flow of post-acute myocardial infarction (MI) patients as a result of standard assessments of left ventricular ejection fraction (LVEF) in the acute phase (≤14 days post- acute MI) and chronic phase (≥40-90 days post-acute MI).
Detailed description
To determine how many patients are referred for sudden cardiac death (SCD) risk stratification and management, indicated for implantable cardioverter defibrillator (ICD), or cardiac resynchronization therapy- defibrillator (CRT-D) implant, and how many receive such devices within 12 months of experiencing an MI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | EP referred group | Referred for sudden cardiac death (SCD) risk stratification and management |
| BEHAVIORAL | Non-Referred group | Not referred for sudden cardiac death (SCD) risk stratification and management. |
Timeline
- Start date
- 2018-11-02
- Primary completion
- 2021-04-16
- Completion
- 2021-05-27
- First posted
- 2018-10-23
- Last updated
- 2024-01-16
- Results posted
- 2024-01-16
Locations
52 sites across 16 countries: Bangladesh, Brunei, China, Egypt, India, Indonesia, Malaysia, Pakistan, Philippines, Saudi Arabia, Singapore, South Africa, South Korea, Taiwan, Thailand, Tunisia
Source: ClinicalTrials.gov record NCT03715790. Inclusion in this directory is not an endorsement.